S Shambharkar, R Tonde, S Nilkhan… - Asian Journal of …, 2024 - indianjournals.com
Remoglifozin, a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor, which
is to be administered as remoglifozinetabonate (Remo™, Remozen™), the prodrug for …